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Animals with genetically determined defects in the development of lymphoid and 
hemopoietic systems have  proven  useful  for understanding  how  these processes are 
normally regulated  (1-4).  There is reason to believe that  New  Zealand strain mice, 
which  have  long  been  used  as  a  model  for  autoimmune  disease,  will  similarly be 
important  for  studies  of B  lymphocyte  differentiation.  These  animals  are  said  to 
develop large numbers of polyclonally activated and  secreting cells together with B 
cells that  are atypical in terms of cell surface Ig and resistance to anti-/t antibodies, 
tolerance,  and  serum  inhibitors  (5-10).  Many  of these  features, which  presumably 
relate to autoantibody formation, have been conferred on normal irradiated recipients 
by grafting with New  Zealand Black mouse  (NZB)  hemopoietic cells (11-15).  Such 
findings suggest that it might be possible to localize defects of their humoral immune 
system to the B  lineage or microenvironmental elements that affect B  cell formation. 
It  has  recently  become  apparent  that  precursor  cells  capable  of  giving  rise  to 
functional  B  cells display distinctive surface antigens and can  mature under  appro- 
priate  culture  conditions  (16,  17).  These  and  other  characteristics  allowed  us  to 
compare such  pre-B cell populations in  bone  marrow  of normal  and  NZB  mice of 
different  ages.  Dramatic  temporal  changes  were  observed  in  the  B  cells and  their 
precursors  in  NZB  bone  marrow,  and  this  indicates  that  B  cell  formation  might 
virtually cease in these animals by adult life. 
Materials  and  Methods 
Animals.  Inbred DBA/2 and BALB/c mice were purchased from Cumberland View Farms, 
Clinton, TN. CBA/H-T6T6, partially immunodeficient CBA/N, and NZB.xid mice were from 
our own colonies. NZB/BinJ mice, obtained from The Jackson Laboratory, Bar Harbor, ME, 
were used  interchangeably with  NZB/umc  mice from our own  colony. Sex-related changes 
were not exhaustively examined in this study, and although it did not obviously influence our 
results, the sex of the animals is indicated in each table and figure. 
Cell Suspensions.  Cell suspensions were prepared, freed of small and large debris, depleted of 
surface immunoglobulin-positive (sIg+) I B cells, and depleted of Sephadex G-10 adherent cells 
exactly as described in our previous reports (17,  18). Thy-l.2-bearing cells were depleted by 
first incubating cells with a  1:200 dilution of monoclonal HO-13-4 antibody (19),  followed by 
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a wash and exposure to a  1:10 dilution of selected rabbit complement for 45 min at 37°C. This 
procedure removed >95% of the Thy-1 + cells in spleen cells, as determined by immunofluores- 
cence. 
Cell Cultures.  Semisolid agar cultures containing  25  /~g/ml  of lipopolysaccharide (LPS), 
2-mercaptoethanol, fetal calf serum (Flow Laboratories, Rockville, MD; lot 29101296), amino 
acids, and vitamins were prepared as described in detail elsewhere (20). Cells lacking surface Ig 
but capable of giving rise to sIg  ÷, clonable B cells were detected by 48-h liquid preculture in 96- 
well microtiter plates (3040;  Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, CA) 
at a density of 106 cells/ml of RPMI 1640 medium with appropriate additives (17). These were 
then harvested, washed, counted, and either examined by immunofluorescence for sIg  + cells or 
plated in semisolid agar cultures. Numbers of proliferating foci were determined after 6-7 d of 
incubation, and all results were expressed in terms of initial cell numbers, to reflect both specific 
cell losses and total numbers of functional B cells that were produced (17). 
Immunofluorescence.  Viable  cells  bearing  sIgM  were  detected  with  F(ab')2  fragments  of 
rhodamine-labeled goat anti-mouse/~ antibodies, and cells containing # chains were detected 
in  acid  ethanol-fixed,  cytocentrifuge  preparations  with  the  same  antibody  as  previously 
described (21). A high molecular weight B-lineage-associated  antigen was detected on cells with 
monoclonal rat  14.8 antibody using purified, fluorescein-labeled mouse anti-rat Ig antibodies 
(22). 
Calculation and Expression of Results.  After each cell separation/manipulation step, numbers 
of nucleated cells were counted and values adjusted to reflect the incidence of the assayed cell 
type in the original suspension. For example, results shown were obtained by depleting sIg  + 
cells and  then  determining the percentages of cells in the resulting suspensions that  stained 
with  14.8 antibody. If 106  initial cells were  placed in  anti-wcoated dishes and  9  ×  10  ~ B- 
depleted cells were recovered before immunofluorescence analysis, then the results would have 
been transformed by multiplication by 0.9. This procedure was used with all of the data that 
were generated at the different time points. It is therefore possible to compare directly any of 
the  findings  that  result  from  examination  of the  same  bone  marrow  suspensions  before 
manipulation,  after  B  cell  depletion,  and  after  liquid  preculture.  Relationships  between 
independent variables were tested by Pearson correlation analysis, and a two-tailed Student's 
t test was used to test significance of differences (23). 
Results 
Precursors in  Adult  NZB Mice.  A  majority of the  B  cells from  marrow  of normal 
mice are removed by incubation in cold, anti-IgM-coated petri dishes, and very few 
cells in the nonadherent  fraction can respond to mitogens in semisolid agar cultures. 
However, if the B  cell-depleted suspensions are incubated in suitable liquid medium 
before plating in  agar, a  substantial number  of sIg  ÷  clonable B  cells are detectable 
(17,  18). Experiments of this kind have yielded similar results when young adult A/J, 
AKR/J,  BALB/cJ,  CBA/H-T6T6,  CBA/J,  C57BL/6J,  C58/J,  DBA/2Cum,  and 
RF/J  mice, or 1-yr-old BALB/c, CBA/H, and DBA/2 mice were studied (17,  18, and 
unpublished observations). In contrast, when  marrow  from NZB mice of at least  16 
wk of age was depleted of B  cells and held in liquid cultures, there was no evidence 
of emergence of functional cells (Table I). This finding corresponds to a low incidence 
of cells in NZB  marrow with distinctive characteristics of B  cell precursors. That  is, 
cells  with  detectable  cytoplasmic  but  not  surface  /~  chains  of IgM  (21)  and  sIg- 
marrow cells bearing a  B-lineage antigen detected by monoclonal  14.8 antibody (22) 
were rare in marrow of these mice. On some occasions, as in this experiment  (Table 
I),  numbers  of  14.8 +  cells  were  reduced  by  more  than  the  expected  amount  by 
incubation in anti-/~-coated plates. Other observations suggest that this might reflect 
depletion of very low density sIg  + cells (unpublished observations). 
Studies of marrow-ablated 89Sr-treated mice suggest that B cells could be formed in JYONOUCHI  ET  AL. 
TABLE  I 
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In primary cultures  Recovered after 48-h 
preculture 
sIg  +  14.8 + 
cells x  cells ×  c#  + cells  Clonable B  sIg  ÷ cells  Clonable B 
10_4  10_4  X  10  -4  cells  ×  10  -4  cells 
NZB bone marrow* 
Unseparated  6.0~  12.0  8,475§  10,880 
Depleted of sIg  + cells  0.1  1.0  0.16  606  0.28  484 
CBA/H bone marrow 
Unseparated  7.1  18.7  4,400  4,329 
Depleted of sIg  + cells  0.1  6.8  4.8  226  3.6  2,152 
* Bone marrow cells were taken from 16-wk-old female mice. 
~: sIg  +,  14.8  +, and c#  + cells are expressed as per 106 initial nucleated cells. 
§ B lymphocyte colonies per 106 initially cultured cells. These data are from a  single experiment and are 
representative of many examinations of mice of this age. 
TABLE  II 
Immediate B Cell Precursors in Bone Marrow, Spleen, and Lymph Nodes of NZB and Control Mice 
In primary cultures  Recovered after 48-h 
preculture 
slg  + ceils  c#  ÷ cells ×  Clonable B  slg  + cells  Clonable B 
X  10  -4  10  -4  cells  ×  10  -4  ceils 
NZB bone marrow* 
Unseparated  6.0:~ 
Depleted of slg  ÷ cells  0.2 
NZB spleen 
Unseparated  17.0 
Depleted of sIg  + cells  0.25 
NZB lymph nodes 
Unseparated  12.0 
Depleted of sIg  + cells  0.2 
BALB/c bone marrow 
Unseparated  8.0 
Depleted of sIg  + cells  0.7 
BALB/c spleen 
Unseparated  39.0 
Depleted of sIg  ÷ cells  0.7 
BALB/c lymph nodes 
Unseparated  15.0 
Depleted of sIg  + cells  0.6 
10,037§  7,056 
0.09  354  0.2  762 
43,650  22,660 
0.06  168  0.02  62 
24,990  15,854 
<0.05  92  0.01  84 
21,700  6,552 
2.5  152  7.76  2,867 
29,400  20,921 
254  39 
5,100  7,235 
419  31 
* Cell donors were 16-wk-old female mice. 
+  +  6  sIg  and cp  ceils are expressed as per 10  initial nucleated cells. 
6  § B  lymphocyte colonies per  10  initially plated cells. These data  are from a  single experiment that  is 
representative of three analyses that included control BALB/c and CBA/H mice of up to 1 yr of age. 
extramedullary  sites in adult  animals  (24).  A  survey  of spleen and  lymph  nodes  from 
16-wk-old  (Table  II)  and  1-yr-old NZB  and  BALB/cJ  mice  (not shown)  did not reveal 
the  presence  of B  cell  precursors  in  these  tissues.  This  indicates  that  formation  of B 
cells in extramedullary  sites is normally  minimal  in either  strain  of animals. 
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than  those  of other  strains  of mice  was  also  tested.  Numbers  of sIg-bearing  and 
functional B  cells were maximal in liquid cultures of B cell-depleted DBA/2 marrow 
after 2-3 d  of incubation, and then  recovery of viable cells declined rapidly (Fig.  1). 
Over this interval there was no evidence of substantial maturation of B cell precursors 
in  cultures  of 4-mo-old  (or  10-mo-old, not  shown)  NZB  marrow.  The  initial back- 
ground of clonable B  cells in sIg- suspensions of younger NZB mice was higher than 
normal (see below), but these did not become more numerous with liquid culture. 
Suppressor and Accessory Cells in NZB Marrow.  Two types of experiments suggest that 
neither abnormalities in thymic-derived cells nor generation of suppressor cells account 
for the failure of adult NZB  marrow to give rise to functional B  ceils in vitro. First, 
depletion of Thy-1-bearing marrow cells had little influence on the cloning efficiency 
of marrow B  cells or formation of B  cells from their immediate precursors in culture 
(Table III). Also, the  addition of NZB  (or  NZB.xid)  marrow  to  cultures of B  cell- 
depleted  DBA/2  marrow  did  not  prevent  the  emergence  of newly  formed  B  cells 
(Table IV).  Our  previous studies  (17)  revealed that  optimum  maturation  of B  cell 
precursors in culture depends on interaction with  accessory cells and that  adherent, 
macrophage-like cells can replace at least one of these. Adherent peritoneal exudate 
cells from  NZB  mice  restored  the  ability of adherent  cell-depleted sIg- cultures  of 
DBA/2  mice to give rise to clonable B  cells (Table V). Adequate accessory function 
was also provided by allogeneic CBA/N  bone marrow  (which lacks clonable B  cells) 
or congenic NZB mice that carry the xid mutation of CBA/N  mice (25). All of these 
experiments indicate that adult NZB marrow is deficient in B  cell precursors rather 
than cells that influence their maturation in vitro. However, the studies performed to 
date  do  not  reveal  what  types  of  regulatory  abnormalities  might  result  in  this 
condition,  and  it  remains  to  be  determined  whether  defects  in  nonlymphoid 
"microenvironmental" elements are responsible. 
Age-related Changes in Bone Marrow Populations.  The composition of NZB and normal 
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FIG.  1.  Kinetics of maturation of slg- precursors in liquid cultures of B cell-depleted bone marrow. 
B cell emergence was detected as sIgM  + cells using immunofluorescence or cells that can clone in 
response to mitogens in semisolid agar cultures. Suspensions were prepared from male 18-wk NZB 
(C)) or male 16-wk DBA/2 (O) mice, and results are expressed as per 106 initial cells.  , clonable 
B cells; .....  , sIg  + cells. JYONOUCHI  ET  AL.  1669 
TABLE III 
Thy-I + Cells Do Not Influence Functional B Lymphocyte Maturation in Liquid Cultures 
Clonable B cells 
Present  Recovered after 
initially  48-h preculture 
NZB bone marrow* 
Unseparated  10,067:[:  7,214 
Depleted ofThy-I  ÷ ceils  7,350  4,606 
Depleted of sIg  + cells  155  472 
Depleted of Thy- 1  + and slg+ cells  115  592 
BALB/c bone marrow 
Unseparated  6,000  9,108 
Depleted of Thy- l + cells  4,648  4,600 
Depleted of sIg  + ceils  123  2,231 
Depleted of Thy- 1  + and sIg  ÷ cells  349  2,190 
* Bone marrow donors were 15-wk-old female mice. 
B cell  colonies per  l0  s initially plated cells.  Essentially similar results 
experiments. 
were obtained in two additional 
TABLE IV 
NZB Bone Marrow Does Not Contain Active Suppressor Cells That Prevent B  Cell Formation 
sIg  + cell-depleted cell suspension 
Recovered after 48-h 
Present initially  precuhure 
sIg  + cells  Clonable  slg* cells  Clonable B 
×  10  -4  B cells  ×  10  -4  cells 
NZB bone marrow*  0.57  606:[:  0.29  444 
DBA/2 bone marrow  0.25  280  3.40  1,754 
NZB +  DBA/2 bone marrow  3.25  2,315 
* Bone marrow donors were male 15-wk-old (NZB) and  14-wk-old (DBA/2) mice. 
B  cell  colonies per  106  initially  plated  cells.  These  data  are  representative  of those obtained  in  five 
separate experiments of this kind. 
TABLE  V 
Influence of Accessogy Cells on B Cell Formation in Liquid Precultures 
Present 
initially 
Clonable B cells recovered after 48-h preculture 
with 
DBA/2  NZB  CBA/N  NZB.xid 
PEC  PEC  marrow  marrow 
NZB bone marrow* 
Depleted of sIg  + cells  460  464 
Depleted of sIg  + and adherent cells  193  34  39  35  41  82 
DBA/2 bone marrow 
Depleted of slg  + cells  61  1,617 
Depleted ofsIg  + and adherent cells  28  53  818  1,231  1,022  1,206 
* Marrow donors were 15-wk-old females, and results are expressed as B lymphocyte colonies detected per 
106 initial cells. 
Liquid cultures were set up with adherent peritoneal exudate cells (PEC) or whole marrow cells as sources 
of accessory cells.  Variations of this experimental  design  were  used  in  six separate  experiments and 
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CBA/H bone marrow was investigated as a function of age. No significant differences 
in total cellularity were noted between  the two strains of mice from birth  to 5 mo of 
age (not shown). In unseparated  bone marrow, the cloning efficiency of NZB cells in 
semisolid  cultures  was elevated  at  all  time points  (Fig.  2).  However, an  age-related 
decline  was obvious for numbers  of sIg  + B  cells  detectable  by immunofluorescence 
and B-lineage cells revealed by staining with monoclonal  14.8  antibody. 
The same specimens were also depleted of Ig-bearing cells with anti-/~-coated dishes 
before analysis  (Fig.  3).  After this  separation,  residual  B cells  (detectable  by immu- 
nofluorescence)  always comprise <1% of the nucleated cells, and nonspecific cell loss 
is  minimal  (26).  B  cell  precursors  detected  by  their  content  of/~  chains  of Ig and 
absence of sIgM were elevated  in 4-5-wk-old NZB mice, and  these declined  rapidly 
after 7 wk of age. This was closely correlated  (r -- 0.8646, P <  0.005)  with changes in 
cells detected by the  14.8 antibody in NZB marrow, and, in fact, numbers of sIg-,c/l  + 
cells were nearly equivalent to sIg-, 14.8 + cells at all times after 3 wk of age (compare 
Fig.  3 a  and 3 b).  All identifiable  cells of the B  lineage in these mice might therefore 
synthesize and/or display Ig chains. In contrast, in normal CBA/H marrow, numbers 
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F~G.  2.  Age-dependent changes  in  bone marrow  B  cel]s detectable by  immunofluorescence  (A), 
cells bearing a B-lineage antigen detected with  monoclona]  14.8 antibody (B), and clonab]e B cells 
(C). Each point represents the mean +  SD of results from 3-4 NZB  (O) or CBA/H-T6T6  (0) mice. 
These data and those presented in  Figs. 3 and 4 were derived from the same sampies and  are 
expressed such that they can be directly compared (see Materials and Methods). JYONOUCHI  ET  AL.  1671 
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FIG. 3.  The specimens described  in  Fig. 3 were depleted of slg  + cells by incubation  in cold, 
antibody-coated dishes and then assayed for cells containing # heavy chains of IgM (A), bearing a 
B-lineage antigen (B), and capable of clonal proliferation ((2).  O, NZB mice; 0, CBA/H mice. Note 
that different scales were used for Fig. 2C and Fig. 3C. 
of slg-,qt  +  cells were  relatively constant  and  were  usually exceeded  by slg-,  14.8 + 
cells at all ages. 
It is noteworthy that  although >90%  of the functional B  cells in CBA/H  marrow 
were  depleted  along  with  Ig-bearing  cells  at  all  ages,  a  substantial  number  of 
"background" clonable cells were seen in NZB marrow suspensions. That  these were 
lymphoid colonies was proven by their complete sensitivity to anti-ft antibodies added 
to the cultures (not shown). 
The influence of age on the incidence of cells in NZB marrow that could give rise 
to slg  + and clonable B  cells in vitro was striking (Fig. 4).  That  is, they increased in 
very  young  animals  to  exceed  normal  values  at  4-5  wk  of age  and  then  rapidly 
declined. It is interesting that  the incidence of sIg-,cft  + cells in NZB marrow closely 
correlated with numbers of clonable B  cells (r =  0.9259;  P  <  0.001)  and numbers of 
sIg  + cells (r -  0.8293;  P <  0.005) arising after liquid culture. Similar concordance was 
seen between sIg- cells detected with the 14.8 antibody and numbers of B cells arising 
in liquid cultures. However, these were not significantly correlated in normal CBA/H 
mice (P >  0.05). 
All of these findings indicate that  non-Ig synthesizing B-lineage cells diminish in 
very young NZB mice, and this is followed by parallel declines in immediate precursors 1672  PRE-B  CELLS  IN  NZB  MICE 
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Flo.  4.  The same B cell-depleted bone marrow samples described in Fig. 3 were placed into liquid 
cultures for 48 h. Recovered cells were tested for sIg expression (A)  or ability to clone in semisolid 
agar cultures (B). C), NZB mice; O, CBA/H mice. 
of B  cells detected  by c/t expression or ability to mature in culture.  In preliminary 
studies  (with  Dr.  D.  Harrison of The Jackson  Laboratories), marrow from 2-yr-old 
CBA/J mice was found phenotypically and functionally to tend to resemble that of 
adult  NZB  mice, and  this suggests  that  the deficiency of B  cell precursors in  these 
animals might be explained in terms of an accelerated aging process. 
Discussion 
There  have  been  many  reports  describing  abnormalities  in  development  and 
function of the humoral immune system of New Zealand strain mice, but this is the 
first  investigation  of the  immediate  precursors  of B  cells  in  animals of this  strain. 
Three independent  assessments indicated that such cells decline to almost undetect- 
able numbers in bone marrow by the time the animals are mature. At that  time it 
was  not  obvious  that  suppressor  cells  were  directed  to  that  compartment  or  that 
accessory cells were defective. These observations call attention to age-related changes 
that occur in this model of autoimmune disease and suggest that further investigation 
will provide insight into processes that normally regulate B lymphocyte formation. 
The  functional  assay for B  cell  precursors  that  was used  in  this  study  has  been 
described and  discussed  in detail elsewhere  (16-18).  It is based on the finding that 
such sIg- cells have little ability to clone in semisolid agar cultures but acquire this 
after preincubation in conventional liquid tissue culture medium. Efficient formation 
of sIg-bearing and clonable B cells in this interval depends on close interaction with 
accessory cells, one type of which can be replaced by adherent peritoneal macrophages 
(17,  and Table V).  Adult  (>15-wk-old)  NZB marrow contained  few sIg- cells that 
gave rise  to  B  cells  in  liquid  culture,  and  these  were  not  rescued  by  addition  of 
adherent peritoneal exudate cells from normal DBA/2  mice. Furthermore, if defects JYONOUCHI  ET AL.  1673 
in regulatory cells were present in NZB marrow, one might expect also to find them 
in  congenic  NZB.xid  mice  (25).  That  is,  the  defective  xid  gene  that  has  been 
backcrossed onto  these  animals should  selectively render  their  B  cells  incapable  of 
responding  in  semisolid cultures,  but  all other cells,  including  microenvironmental 
elements,  should  be of NZB  type.  Marrow  from  these  animals  was  as  effective as 
CBA/N marrow in supporting the terminal differentiation of precursors from adherent 
cell-depleted DBA/2 marrow (Table V). All of this indicates that adherent accessory 
cells in NZB marrow and peritoneal exudate are probably normal. In an earlier study, 
we  obtained  indirect  evidence  for  a  type  of nonadherent  accessory cells  that  are 
present  in adult  marrow but limiting in fetal liver (17).  The present studies  do not 
directly test the competence of such cells in NZB mice. One approach to this question 
is to enrich putative B cell precursors from normal and NZB marrow (using mono- 
clonal  14.8  antibody)  and  place  them  in  culture  with  various  sources  of accessory 
cells.  In several experiments of this  kind,  positively selected B  cell  precursors  from 
CBA/H  marrow  matured  normally  when  cultured  with  NZB.xid  marrow  (H. 
Jyonouchi, unpublished observations). 
Mice injected with C. parvum  develop prostaglandin-secreting suppressor cells that 
selectively inhibit  marrow B-lineage cells (18).  It seemed possible that adherent cells 
of this kind or suppressor cells of the T  lineage might be active in adult  NZB mice. 
However, depletion of Thy-1 antigen-bearing cells or appropriate mixing experiments 
did  not  provide evidence for this.  Therefore, our failure to detect  B  cell precursors 
with the liquid culture assay is not attributable to suppressor cells. On the other hand, 
these experiments do not exclude the possibility that immunoregulatory abnormalities 
occurring at an early age resulted in the deficiency detected in adult animals. 
We recently described a group of monoclonal antibodies (including clone 14.8) that 
detect an antigen that is displayed on ceils of the B lineage from an early stage (22). 
It appears that  virtually all Ig-bearing cells as well as c/t  + cells and precursors that 
can quickly give rise to functional  B cells are recognized by this antibody (27). The 
incidence of 14.8 + cells that did not bear Ig steadily declined in NZB mice after 5 wk 
of age and  closely corresponded  with  changes  in  sIg-,c/t  + cells.  In  fact,  it  appears 
likely  that  from 4  wk  of age  these  two  categories of cells  were  almost  completely 
overlapping in NZB mice. This follows from the fact that all c#  + cells in marrow are 
14.8 +  (27)  and from comparison of the  incidences  of these among sIg- populations 
(Fig.  3 a  and 3 b). In normal CBA/H marrow, on the other hand,  numbers of sIg-, 
14.8 + cells exceeded c/t  + cells, and the sizes of these two populations  did not closely 
correspond during ontogeny. 
One interpretation of these results is that a category of early B cell precursors with 
the phenotype sIg-,c/t-,14.8  + rapidly disappear after 3 wk of life in NZB mice, and 
this leads to a premature shutdown of myeloid B cell production. This might indicate 
that regulation of B cell formation normally is controlled at the level of such cells. In 
this  context,  it  is  noteworthy that  anti-/t suppression  experiments indicate  that  the 
rate of small lymphocyte formation in  marrow is  not  influenced  by the size of the 
mature B cell pool (28). However, in addition to the B lineage,  14.8 antibody at least 
weakly binds to subpopulations of peripheral T  cells, and the contribution of these to 
non-Ig synthesizing,  14.8 + populations in normal marrow remains to be determined. 
The  close  correlation  of  precursors  detected  by  cytoplasmic  ~  chains  with  14.8 
antibody or by means of the liquid culture assay in NZB mice might also minimize 1674  PRE-B CELLS IN NZB MICE 
doubts about the relevance of c#+,sIg  -  cells to normal B-lineage differentiation  (29, 
30). 
When slg  + ceils were removed from suspensions of lymph node cells with anti-Ig- 
coated  petri  dishes,  clonable  B  cells  were  diminished  by >95%.  This  provides  an 
indication of the efficiency of B cell depletion with this separation technique because 
lymph nodes are not thought  to contain precursors of B cells (16).  Usually no more 
than  t0% of the functional B cells in normal adult bone marrow suspensions remain 
after this procedure, and we concluded that the immediate precursors of B cells must 
have little ability to proliferate in these mitogen-containing, semisolid agar cultures 
(26).  In  the  present  study,  we  noted  that  young  NZB  marrow  gave a  significant 
number of "background" colonies when plated after B cell depletion  (Fig. 3 c). That 
these were lymphoid colonies was determined by the fact that inclusion of anti-# in 
the semisolid cultures completely prevented their proliferation. We also found some 
cells of this kind in liver and spleen of normal newborn CBA/H mice (H. Jyonouchi, 
unpublished  observations). It is possible that these represent precursors that are just 
hours away from acquiring sIg and functional capability. They might also be newly 
formed B  cells that  display Ig in  insufficient  quantities  to adhere  to the antibody- 
coated dishes or to be detected by immunofluorescence microscopy. Another possibility 
to be considered is that  the B  cell precursors of young NZB mice might be able to 
mature even in semisolid cultures. A possibly related finding was that B cell precursors 
as well as functional B cells were consistently elevated in very young NZB mice. This 
could  reflect  a  period  of hyperactivity in  which  B  cells  are  being rapidly  formed. 
Further studies of this critical age might reveal whether this is intrinsic to the B cell 
precursors or attributable to accessory cells that influence B cell maturation  (17). 
The age-related changes  that occur in B  lymphocyte precursors of NZB mice are 
particularly interesting. Our assay procedures make it possible to estimate the size of 
the compartment that  immediately precedes sIg  + functional  B cells but do not give 
direct information about the rate of the pre-B to B cell transition.  However, it seems 
unlikely  that  substantial  numbers  of B  cells emerge from precursors in  NZB  mice 
after 15 wk of age. Radioactive thymidine incorporation studies indicate that the rate 
of total small lymphocyte formation might gradually  decline  in  marrow of normal 
C3H mice after 4 wk of age (28,  31). On the other hand, transplantation experiments 
suggest  that  during an entire normal lifespan,  muhipotential  stem cells do not lose 
their potential  for forming lymphoid and  myeloid cells  (32-33).  We have initiated 
studies with very old normal CBA strain mice and found that B cell precursors were 
reduced  at  2  yr  but  not  at  8-10  mo  of age  (Landreth,  Jyonouchi,  Kincade,  and 
Harrison, unpublished observations). Furthermore, numbers ofclonable B cells decline 
prematurely in  NZB mice, and  this is  first obvious with  bone marrow populations 
(34,  and  unpublished  observations).  New Zealand  mice might  therefore provide a 
model  for  genetically  determined,  premature  senescence  of the  humoral  immune 
system, and this is consistent with the well-known early involution of the thymus in 
these animals (7).  One prediction of these findings is that the repertoire of antibody 
specificities could become restricted with time in NZB mice. That is, if maintenance 
of diverse antibody responsiveness depends on constant input of newly formed B cells, 
this might not occur in these animals. 
There are a  number of clearly documented abnormalities of the humoral immune 
system in NZB mice. These include their development of large numbers of polyclonal JYONOUCHI  ET  AL.  1675 
Ig-secreting cells  and  clonable  B  cells  that  include  an  unusual  sIgM  + subset  that 
proliferates in LPS-potentiated cultures in the presence of anti-# antibodies (5, 34). In 
adult mice, the most unique cell surface distinction is a  reduced ratio of/~:6 chains, 
and  this  is  especially noteworthy on  large  splenic  and  lymph  node  cells  (35-37). 
Studies of resistance of NZB B cells to tolerance have yielded conflicting and variable 
results, and it appears that the increased resistance of these mice to in vivo induced 
tolerance is largely attributable  to T  lineage and  hormonal defects  (9,  15,  37,  38). 
Reports of cell transfer experiments and studies of athymic NZB and NZB.xid mice 
seem to negate the importance of T cell abnormalities in production of autoantibodies 
and various B cell changes in NZB mice (9, 11, 38, 39). However, it has recently been 
shown that very small numbers of T  cells can influence immune responses that were 
formerly thought to be T  independent (40-42). 
It now seems crucial to evaluate all findings relating to B cell defects in chronological 
terms, that  is, whether abnormalities appear earlier than autoantibody production, 
earlier than other known defects, and consistently in all individuals. The development 
of significant  numbers  of polyclonal Ig-seereting cells was  said  to occur in  T  cell- 
depleted cultures of neonatal cells and reproducibly in all NZB mice from birth (43, 
44). Our own experience with Ig-secreting cells measured by reverse plaque-forming 
cell assay  (unpublished observations)  is more like that  reported by Izui et al.  (45), 
where animal-to-animal  variation was  substantial,  and  significant  differences were 
not consistent before several weeks of age. Also, in other reports, B cell abnormalities 
were not remarkable in very young NZB mice (36, 37). 
We recently found (14) that it was possible to reciprocally transfer myeloid and B 
lymphoid abnormalities of NZB to DBA/2 mice by whole marrow transplantation. 
This followed reports that potential for autoimmune disease could be transferred with 
hemopoietic cells  (11-13).  Similarly, DBA/2  mice that were irradiated and  grafted 
with NZB marrow later had a deficiency of B cell precursors, and NZB recipients of 
DBA/2 cells were found to have a normal incidence of these (46).  Further dissection 
of this model might reveal whether intrinsic B-lineage defects or transferable, microen- 
vironmental elements are responsible. It is also known that expression ofautoimmunity 
and other NZB characteristics is under multigenic control (9, 47). Careful analysis of 
recently developed recombinant inbred lines  (47,  48)  might indicate whether accel- 
erated  aging  of the  humoral  immune  system  is  related  to  any  of these.  Another 
question under investigation is whether stern cells that precede 14.8-expressing ceils 
prematurely decline in NZB mice. Such information could be helpful in identifying 
critical stages in B-lineage differentiation that are subject to regulation. 
Summary 
Adult NZB mice (>15 wk old) have very few bone marrow cells that can give rise 
to sIg  + clonable B cells during liquid culture. This deficiency corresponds to extremely 
low numbers of cells with cytoplasmic but not surface/.t chains of IgM and reduced 
numbers of cells bearing  a  high  molecular weight  B-lineage antigen.  Depletion of 
Thy-l-bearing cells and  appropriate mixing experiments did not  provide evidence 
either that suppressor cells are responsible for this phenomenon or that accessory cells 
are  defective in  NZB  mice.  Nor did  it  seem  that  B  cells  were  being  produced  in 
extramedullary sites.  B  cell  precursors  were  detectable  in  very young NZB  mice, 
exceeded control values at 4-5 wk of age, and then declined rapidly. In contrast, these 1676  PRE-B  CELLS  IN NZB  MICE 
persisted for >  1 yr in normal BALB/c, DBA/2, and CBA/H  mice. It appears possible 
that  intermediate stages in B-lineage differentiation become prematurely exhausted 
through an accelerated aging process in NZB mice. These chronological changes have 
implications  for  understanding  the  sequence  of events  that  lead  to  B  lymphocyte 
formation and the processes that normally regulate it. 
Received  for publication 17 February 1982. 
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